In a letter to the drugmaker, the FDA said the agency approved Beyfortus, an RSV monoclonal antibody, as a defense against RSV lower respiratory tract disease — but that Sanofi has been claiming it protects broadly against RSV disease, which occurs in the lower and upper tracts. Beyfortus has come […] The post Sanofi Made False Claims About RSV Shot for Infants, FDA Says appeared first on Activist Post.
Source: https://www.activistpost.com/sanofi-made-false-claims-about-rsv-shot-for-infants-fda-says/
Author: Editor
